Clarke, J. M., Simon, G. R., Mamdani, H., Gu, L., Herndon, J. E., Stinchcombe, T. E., Ready, N., Crawford, J., Sonpavde, G., Balevic, S., Nixon, A. B., Campa, M., Gottlin, E. B., Li, H., Saxena, R., He, Y. W., Antonia, S., Patz, E. F. (2025). Complement factor H targeting antibody GT103 in refractory non-small cell lung cancer: a phase 1b dose escalation trial. Nature Communications. https://doi.org/10.1038/s41467-024-55092-2